Advertisement
Baxter International
Subscribe to Baxter International

The Lead

Baxter Splitting into Two Separate Businesses

March 28, 2014 2:09 pm | by Linda A. Johnson, AP Business Writer | News | Comments

Following a rival's lead, Baxter International Inc. said it's planning a breakup into two health care companies as it tries to boost innovation and profitability and reward shareholders. Thursday's news could mark a recent trend as Wall...

‘Smart’ Infusion Pumps See Fast Growth

January 31, 2014 11:58 am | by Kalorama Information | News | Comments

New "smart" infusion pump devices that can assist healthcare professionals in patient care...

Nikkiso closes buyout of Baxter's renal business

January 10, 2014 1:14 pm | by Mass Device | News | Comments

Nikkiso America said it closed the buyout of Baxter's continuous renal replacement therapy...

Baxter lands CE Mark for VIVIA multi-setting hemodialysis system

December 20, 2013 1:52 pm | by Mass Device | News | Comments

Illinois medical device maker Baxter's won European regulatory approval for its VIVIA...

View Sample

FREE Email Newsletter

Layoffs: Baxter axes nearly 100 from New York facility amid FDA inquiry

September 30, 2013 12:17 pm | by Mass Device | News | Comments

Healthcare giant Baxter announced that it fired nearly 100 employees from a Medina, N.Y., amid an FDA inquiry into the Sigma Spectrum infusion pump manufactured there. The FDA has asked Baxter to provide additional information into modifications proposed for the medical device, forcing Baxter to suspend shipments since April of this year.

Baxter appeases EU regulators in $4B Gambro buyout

August 22, 2013 12:51 pm | by Mass Device | News | Comments

After months of negotiations with EuroZone regulators, Baxter's (NYSE:BAX) nearly $4 billion buyout of Swedish dialysis maker Gambro AB can go forward now that Baxter agreed to sell off its renal replacement therapy division to ease anti-trust concerns.

Sources say Baxter's near an agreement with EU regulators in $4B Gambro merger

July 11, 2013 4:45 pm | by Mass Device | News | Comments

Healthcare giant Baxter (NYSE:BAX) may be on the verge of closing its $4 billion buyout of Swedish dialysis devices maker Gambro AB after offering to divest some of its assets in order to appease European regulators, according to anonymous sources cited by Reuters.

Advertisement

Baxter Taps New Technologies, Forms Collaborations to Improve Environmental Sustainability and Access to Healthcare

April 2, 2013 9:00 am | by The Associated Press | News | Comments

DEERFIELD, Ill.--(BUSINESS WIRE)--Apr 2, 2013--Baxter International Inc. (NYSE: BAX) is incorporating innovative technologies and has recently established new partnerships in its commitment to environmental sustainability and increasing access to healthcare. Recently the company initiated...

M&A: The top 15 acquirers among medical device companies

August 6, 2012 3:37 pm | by Mass Device | News | Comments

A look at the most acquisitive medical device companies, culled from MassDevice.com's Big 100 database of more than 1,300 medical device industry transactions. More than $50 billion was spent on acquisitions by Big 100 medical device companies from the beginning of 2011 through the 1st half of 2012.

Baxter rises on growth in emerging markets

July 20, 2012 2:41 pm | by Mass Device | News | Comments

Baxter International's bets in emerging markets pay off during the 2nd quarter with growth in plasma sales. Baxter (NYSE:BAX) reported modest growth in sales and a healthy surge in profit during the 2nd quarter, which the company attributed partially to increasing demand for its plasma products in emerging markets.

Baxter Announces FDA Approval of Expanded Indication for TISSEEL [Fibrin Sealant] for General Hemostasis in Surgery

January 31, 2012 5:53 am | News | Comments

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved TISSEEL [Fibrin Sealant] to include general hemostasis in surgery when control of bleeding by standard surgical techniques is ineffective or impractical.

Baxter Appoints Jean-Luc Butel as President, International

January 11, 2012 4:46 am | News | Comments

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. announced today that Jean-Luc Butel has been appointed corporate vice president and president, international, reporting to Robert L. Parkinson, Jr., chairman and chief executive officer. He will assume his new role on February 20, 2012.

Baxter Introduces NUMETA in Europe as the First-Ever Triple-Chamber IV Nutrition System for Preterm Newborns and Children

November 7, 2011 5:40 am | News | Comments

HANOVER, Germany--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) announced today the European launch of NUMETA (emulsion for infusion). NUMETA was introduced at the 22nd Annual European Society of Pediatric and Neonatal Intensive Care (ESPNIC) Medical...

Advertisement
X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading